Healthcare marketing trends 2026.
What's actually changing in Australian healthcare marketing in 2026, drawing on what we observe across our 25-active-client healthcare book. Not predictions. Not industry trends decks. The shifts we're navigating with our clients in real time.
1. AHPRA's cosmetic advertising standards have teeth
AHPRA's cosmetic advertising standards now have meaningful enforcement attention. Aesthetic and cosmetic clinics that previously ran loose patient-testimonial advertising are getting compliance prompts, and the prompts now get followed up. The agencies that have been running AHPRA-compliant pipelines all along (us) are unaffected; the agencies that have been running aesthetic-clinic advertising the way you'd run e-commerce paid social are scrambling. Our aesthetic-clinic engagements run with the discipline this enforcement environment requires.
2. GP supply marketing is now flagship-channel
Australian primary care groups have been quietly aware of GP supply pressure for years. In 2026 it's everyone's number-one operational issue, and recruitment marketing budgets are now sitting alongside (sometimes exceeding) patient acquisition budgets. We've been running GP recruitment as its own paid-media programme for For Health and Partnered Health for two years. The agencies that haven't built the discipline are being out-recruited.
3. Multi-site WordPress CMS as PE-portfolio infrastructure
For PE-backed multi-clinic groups, the WordPress + plugin-fragility era is ending. WordPress multi-site architecture is now the default for healthcare-grade clinical sites at scale. Our 22% of revenue running on WordPress isn't an accident, it's where the multi-clinic healthcare market is operationally heading. Agencies without WordPress capability are getting locked out of PE-portfolio engagements.
4. AI-augmented clinical content with documented governance
AI-augmented clinical content production is now economically necessary at retainer scale. The question for healthcare clients is no longer "do you use AI?", it's "how is the AI governed?" For our regulated clients, every output carries provenance metadata: which model, which prompt, who reviewed and approved, when it was published. AHPRA review on every patient-facing output. Documented governance policy available on request. Agencies producing clinical content via AI without documented governance are accumulating regulatory exposure quietly.
5. Multi-location GBP at scale is a moat
Generic marketing agencies can run a Google Business Profile listing. Running 60+ GBP listings across multiple brand identities, with citation hygiene maintained, location-page architecture aligned, review acquisition pipelines firing per location, that's an operational discipline that takes years to build and is genuinely scarce in the Australian market. For multi-clinic groups with 30+ locations, it's now a competitive moat.
6. Telehealth marketing has stabilised
The 2020-2023 telehealth-everything period is over. Telehealth has stabilised as a channel for specific conditions (mental health, GP triage, certain specialist consultations) and is now part of the integrated booking flow rather than a stand-alone offering. Marketing programmes that treat telehealth as a separate "telehealth landing page" rather than an integrated booking option are missing the actual buyer behaviour.
Read more:
Running a healthcare marketing programme in 2026?
Forty-five-minute call. We'll review your AHPRA compliance posture, your GP supply programme, your CMS architecture, and your AI governance.
Book a Discovery